This trial will study the effects of an executive function training program on cognition and mobility in three groups of adults: those with age-related hearing loss, those with normal hearing, and middle-aged adults.
- Age-Related Hearing Loss
10 Primary · 20 Secondary · Reporting Duration: baseline
Awards & Highlights
2 Treatment Groups
1 of 2
Executive function (EF) training
1 of 2
120 Total Participants · 2 Treatment Groups
Primary Treatment: Executive function (EF) training · No Placebo Group · N/A
Who is running the clinical trial?
Age 45 - 80 · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What objectives are researchers hoping to accomplish with this research endeavor?
"This clinical trial's primary outcome is measuring the accuracy of multi-talker word perception following training. Additionally, participants will also be evaluated on their verbal memory using the Rey Auditory Verbal Learning Test (RAVLT), subjective balance confidence with the ABC Balance Confidence Questionnaire, and global cognitive status through a Montreal Cognitive Assessment (MoCA)." - Anonymous Online Contributor
Is enrollment into this experiment still available?
"Clinicaltrials.gov confirms that this clinical trial is actively recruiting patients; the study was initially announced on August 30th 2020 and has been updated as recently as June 9th 2022." - Anonymous Online Contributor
Could I qualify to take part in this research?
"Those willing to be part of this research must have presbycusis and fall within the age range between 45 and 80. The trial is currently searching for roughly 120 volunteers." - Anonymous Online Contributor
Does this research encompass participants who have attained 18 years of age?
"This medical trial requires the participation of patients aged 45-80. However, there are 55 trials for minors and 367 for seniors outside this age range." - Anonymous Online Contributor
What is the enrollment count for this research endeavor?
"Affirmative. According to information featured on clinicaltrials.gov, the trial which was initially announced on August 30th 2020 is actively seeking participants. The study requires 120 patients from a single site." - Anonymous Online Contributor